Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system

Physiology and Behavior

Volumn 129, Issue , 2014, Pages 73-78

  Gupta, Deepali ^a   Kurhe, Yeshwant ^a   Radhakrishnan, Mahesh ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Antidepressant; Depression; Diabetes; Insulin; Monoamine oxidase; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ESCITALOPRAM; GLUCOSE; INSULIN GLARGINE; SEROTONIN; AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CITALOPRAM; GLUCOSE BLOOD LEVEL; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR; BLOOD GLUCOSE MONITORING; BODY WEIGHT; BRAIN HOMOGENATE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; FORCED SWIM TEST; GLUCOSE BLOOD LEVEL; HOPELESSNESS; IMMOBILITY; INSULIN TREATMENT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TAIL SUSPENSION TEST; ANIMAL; BRAIN; COMPLICATION; DEPRESSIVE DISORDER; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; INSULIN; MALE; MICE; MONOAMINE OXIDASE; MOTOR ACTIVITY; SEROTONIN; STREPTOZOCIN;

EID: 84896034951     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.02.036     Document Type: Article

References (44)

1. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of comorbid depression in adults with type 2 diabetes: a systematic review and meta analysis. Diabet Med 2006, 23:1165-1173.
2. Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H. Diabetes, depression, and quality of life a population study. Diabetes Care 2004, 27:1066-1070.
3. Roy T., Lloyd C.E. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012, 142:S8-S21.
4. Park M., Katon W.J., Wolf F.M. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 2013, 35:217-225.
5. Talbot F., Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care 2000, 23:1556-1562.
6. Egede L.E., Nietert P.J., Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28:1339-1345.
7. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J., et al. Melanin concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 2001, 107:379-386.
8. Gerozissis K. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 2003, 23:1-25.
9. Qiu W.Q., Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging 2006, 27:190-198.
10. Park C.R. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001, 25:311-323.
11. Ho N., Balu D.T., Hilario M.R., Blendy J.A., Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol Behav 2012, 105:702-708.
12. Wayhs C.A.Y., Manfredini V., Sitta A., Deon M., Ribas G., Vanzin C., et al. Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect. Metab Brain Dis 2010, 25:297-304.
13. Haider S., Ahmed S., Tabassum S., Memon Z., Ikram M., Haleem D.J. Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats. Acta Neurol Belg 2013, 113:35-41.
14. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965, 122:509-522.
15. Rajkumar R., Mahesh R. Assessing the neuronal serotonergic target based antidepressant stratagem: impact of in vivo interaction studies and knockout models. Curr Neuropharmacol 2008, 6:215-234.
16. McCall A.L. The impact of diabetes on the CNS. Diabetes 1992, 41:557-570.
17. Yamato T., Misumi Y., Yamasaki S., Kino M., Aomine M. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 2004, 17:128-136.
18. Kino M., Yamato T., Aomine M. Simultaneous measurement of nitric oxide, blood glucose, and monoamines in the hippocampus of diabetic rat: an in vivo microdialysis study. Neurochem Int 2004, 44:65-73.
19. Souza L.C., Carlos Filho B., Fabbro L.D., de Gomes M.G., Goes A.T., Jesse C.R. Depressive-like behavior induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-α and thalidomide therapies. Behav Pharmacol 2013, 24:79-86.
20. Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes 1986, 35:481-485.
21. Fernstrom J.D., Wurtman R.J. Brain serotonin content: increase following ingestion of carbohydrate diet. Science 1971, 174:1023-1025.
22. Fernstrom J.D., Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972, 178:414-416.
23. Mackenzie R.G., Trulson M.E. Effects of insulin and streptozotocin induced diabetes on brain tryptophan and serotonin metabolism in rats. J Neurochem 1978, 30:205-211.
24. Schulingkamp R.J., Pagano T.C., Hung D., Raffa R.B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000, 24:855-872.
25. Eren I., Naziroglu M., Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 2007, 32:1188-1195.
26. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
27. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressant drugs. Psychopharmacology (Berl) 1985, 85:367-370.
28. Ramamoorthy R., Radhakrishnan M., Borah M. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behavior-based rodent models. Behav Pharmacol 2008, 19:29-40.
29. Krstulovic A.M., Powell A.M. Use of native fluorescence measurements and stopped-flow scanning technique in the high-performance liquid chromatographic analysis of catecholamines and related compounds. J Chromatogr A 1979, 171:345-356.
30. Davis T.P., Gehrke C.W., Cunningham T.D., Kuo K.C., Gerhardt K.O., Johnson H.D., et al. High-performance liquid-chromatographic separation and fluorescence measurement of biogenic amines in plasma, urine, and tissue. Clin Chem 1978, 24:1317-1324.
31. Schurr A., Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem Pharmacol 1976, 25:1201-1203.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
33. Castagne V., Moser P., Roux S., Porsolt R.D. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 2011, 55:11-18.
34. Hirano S., Miyata S., Kamei J. Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2007, 86:27-31.
35. Colla A.R., Machado D.G., Bettio L.E., Colla G., Magina M.D., Brighente I., et al. Involvement of monoaminergic systems in the antidepressant-like effect of Eugenia brasiliensis Lam. (Myrtaceae) in the tail suspension test in mice. J Ethnopharmacol 2012, 143:720-731.
36. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 2005, 182:335-344.
37. 1B receptors in the antidepressant-like effect of piperine in the forced swim test. Neurosci Lett 2011, 504:181-184.
38. 3 receptor antagonist, in animal models of depression. Pharmacol Rep 2010, 62:245-257.
39. Tota S., Awasthi H., Kamat P.K., Nath C., Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 2010, 209:73-79.
40. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
41. Kamei J., Miyata S., Morita K., Saitoh A., Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2003, 75:247-254.
42. Liu Y., Jia G., Gou L., Sun L., Fu X., Lan N., et al. Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress. Pharmacol Biochem Behav 2013, 104:27-32.
43. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2007, 33:73-83.
44. Sacher J., Wilson A.A., Houle S., Rusjan P., Hassan S., Bloomfield P.M., et al. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry 2010, 67:468-474.